chalcone has been researched along with Alveolar Bone Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camilli, AC; Fernandes, NAR; Guimarães-Stabili, MR; Maldonado, LAG; Molon, RS; Pacheco, CGP; Regasini, LO; Ribeiro de Assis, L; Rossa Junior, C; Silva, AF; Spolidorio, LC | 1 |
1 other study(ies) available for chalcone and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro.
Topics: Alveolar Bone Loss; Animals; Bone Resorption; Cell Differentiation; Chalcone; Chalcones; Mice; Osteoclasts; Osteogenesis; RANK Ligand; Rats | 2021 |